Medtronic to webcast renal denervation investor & analyst briefing on november 7

Dublin , oct. 14, 2022 /prnewswire/ -- medtronic plc (nyse:mdt), a global leader in healthcare technology, today announced the company will host a webcast to provide an update on its medtronic coronary and renal denervation business during the american heart association annual scientific sessions (aha 2022) on monday, november 7, 2022, at 5 p.m. cst. the webcast will feature remarks from medtronic coronary and renal denervation management, including comments on the 6-month results from the spyral htn-on med randomized trial (on med).
MDT Ratings Summary
MDT Quant Ranking